netFormulary North Central London NHS
Joint Formulary  
 Search
 Formulary Chapter 6: Endocrine system - Full Chapter
06.05.02  Expand sub section  Posterior pituitary hormones and antagonists
06.05.02  Expand sub section  Posterior pituitary hormones
Desmopressin
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • DDAVP: On formulary
    • DesmoMelt: Formulary for use as a first line agent in the treatment of primary nocturnal enuresis
  • RFL:
    • DDAVP: Restricted to child health; sublingual tablets available (120micrograms and 240micrograms)
    • Desmotabs: Restricted to child health
    • Desmospray: On formulary
    • Octim: On formulary
    • Injection: 4micrograms in 1mL available
  • RNOH:
    • Tablets, Injection, Nasal spray (for continuation of treatment), Oral lyophilisates (for continuation of treatment)
  • UCLH:
  • WH:
    • DDAVP: Intranasal solution 100 micrograms/1 ml & Inj 4 micrograms/1 ml ONLY
    • DesmoMelt: The use of Desmomelt tablets is restricted to Paediatrics only
    • Desmotabs: The use of desmopressin tablets is restricted to Dr Rossi only
    • Desmospray: On Formulary
 
   
Terlipressin (Glypressin)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Approved for use in hepato-renal syndrome (JFC January 2018)
    • Restricted to Hepatology (bleeding oesphageal varices)
  • RNOH:
    • Store in a refrigerator
  • UCLH:
  • WH:
    • No restriction stated

 

 
   
Argipressin
(Vasopressin, synthetic)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Store in a refrigerator
  • UCLH:
  • WH:
    • Non-formulary
 
   
06.05.02  Expand sub section  Antidiuretic hormone antagonists
 ....
 Non Formulary Items
Terlipressin  (Variquel)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

GP - 1st

Medicines suitable for first-line use within primary care.

Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing.

  

GP - 2nd

Medicines suitable for second-line use within primary care.

Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing.

  

GP - Amber

Medicines that should be initiated by a specialist. Prescribing can be transferred to primary care once the patient has been stabilised.

Shared care: For drugs with regular, ongoing need for monitoring and/or assessment of efficacy or toxicity. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the North Central London JFC.

Fact sheet: For drugs with some concerns surrounding safety or efficacy but do not require regular monitoring and/or monitoring of effectiveness/toxicity.

  

GP - Red

Medicines which should normally be prescribed by specialists only (hospital only).

For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.

  

GP - Grey

Medicines on hospital formularies which have not been reviewed for suitability in primary care.  

Black

Medicines not recommended for routine use in primary or secondary care.

Medicines, which the North Central London JFC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.

  

netFormulary